[Primary systemic amyloidosis with involvement of the heart and coronary arteries].
Boldueva
S A
SA
Samokhvalova
M V
MV
Bogdanova
E V
EV
Solov'eva
T S
TS
D000368:Aged; D058227:Amyloidogenic Proteins / Q000097:blood; D000686:Amyloidosis / Q000150:complications / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D001808:Blood Vessels / Q000473:pathology; D003933:Diagnosis; D003937:Diagnosis, Differential; D018450:Disease Progression; D004232:Diuretics / Q000627:therapeutic use; D004562:Electrocardiography; D017809:Fatal Outcome; D006333:Heart Failure / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006501:Hepatic Encephalopathy / Q000097:blood / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000209:etiology / Q000503:physiopathology / Q000628:therapy / Q000652:urine; D008297:Male; D017202:Myocardial Ischemia / Q000175:diagnosis; D009206:Myocardium / Q000473:pathology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
D058227:Amyloidogenic Proteins; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D004232:Diuretics; D010975:Platelet Aggregation Inhibitors